GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BFRI · Jun 30, 2025

Biofrontera Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001641172-25-023486General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.01% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation70thOwn-history percentile · N=10

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-33.72% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

15.19% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure30thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

44.61% · OPTIONAL · VALID

Operating margin60thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.operating_margin

-56.25% · CORE · VALID

R&D intensity88thOwn-history percentile · N=8

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

9.63% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

2.07% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building

Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20244/7 normalizedLevel 3 Mar 31, 20254/7 normalizedLevel 3 Jun 30, 20255/7 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20257/7 normalizedLevel 3 Mar 31, 20267/7 normalizedLevel 3 Jun 30, 20267/7 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 0.03%
Current: 0.01%
Delta: -0.02%

Cash Generation Increased

Previous: -47.94%
Current: -33.72%
Delta: 14.22%

Growth Increased

Previous: 8.54%
Current: 15.19%
Delta: 6.65%

Inventory Pressure Decreased

Previous: 76.00%
Current: 44.61%
Delta: -31.39%

Profitability Decreased

Previous: -52.95%
Current: -56.25%
Delta: -3.30%

R And D Intensity Decreased

Previous: 14.05%
Current: 9.63%
Delta: -4.42%

Sbc Intensity Decreased

Previous: 2.78%
Current: 2.07%
Delta: -0.71%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · BFRI Fundamental State →Has State · Biofrontera Inc. →Transitioned To · BFRI Fundamental State →Transitioned To · BFRI CAPEX_INTENSITY_DECREASED →Transitioned To · BFRI CASH_GENERATION_INCREASED →Transitioned To · BFRI GROWTH_INCREASED →Transitioned To · BFRI INVENTORY_PRESSURE_DECREASED →Transitioned To · BFRI PROFITABILITY_DECREASED →Transitioned To · BFRI R_AND_D_INTENSITY_DECREASED →Transitioned To · BFRI SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.